Premier Research Strategist to Discuss Evolving Site Landscape at CNS Summit

DURHAM, N.C., October 26, 2016 — Premier Research’s lead strategist will participate in a panel discussion on the evolving landscape for investigator sites at CNS Summit 2016 in Boca Raton, Florida. Krista Armstrong, Vice President of Strategic Development, will join colleagues in addressing topics such as:

  • Advantages and disadvantages of site consolidation
  • Site selection and strategic site relationships
  • Sponsor criteria for selecting CROs
  • How the new trend in site ownership is affecting selection
  • Increasing competition for sites and patients

The panel discussion, part of a session titled Transforming Site Landscape: Evolving Partnerships & Strategic Alliances, will take place on Friday, October 28, from 1 p.m. to 3 p.m.

Also at this year’s CNS Summit, Premier Research will make two poster presentations:

Dr. Thomas Laage, Senior Medical Director, and Todd Leathers, Executive Director of Drug Development Strategy, will present Management of Clinical Trials with Adaptive Designs during the Friday evening poster session on October 28.

Dr. Laage will present D3: Deuterium Drug Development during the Saturday evening poster session on October 29.

About Premier Research

Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, medical device, neuroscience, oncology, pediatrics, and rare disease. Premier Research operates in 84 countries and employs 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.